Accendra Health Q3 revenue misses; sees full-year revenue at low end of outlook
ACH•Accendra Health reported Q3 revenue of $601.8 million and adjusted EBITDA of $47.8 million, both below analyst expectations. It expects 2026 revenue at the low end of its $2.45 billion-$2.55 billion outlook and adjusted EBITDA as much as 30% below the prior outlook’s $310 million midpoint.
1. Quarterly results
Accendra Health reported Q3 revenue of $601.8 million, below the $617.38 million analyst consensus, and a net loss of $19.7 million. Adjusted EBITDA was $47.8 million, missing the $74.1 million consensus.
2. 2026 outlook
The company expects 2026 net revenue at the bottom end of its $2.45 billion-$2.55 billion range. It said adjusted EBITDA could be up to 30% below the $310 million midpoint of its prior outlook.
3. Turnaround actions
CEO Kenny Gardner-Smith said the company has identified four key areas for transformation and is taking action to improve profitability. Q3 included $5.5 million in exit and realignment charges, mainly related to the sale of a non-core asset and costs tied to strategic initiatives.
